Skip to content

sACB vs cACB in TKA

Comparison of Single-shot vs. Continuous Adductor Canal Block Analgesic Effects With Catheter Positioning Confirmation in Total Knee Arthroplasty: a Double-blinded Prospective Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07581886
Enrollment
78
Registered
2026-05-12
Start date
2026-05-18
Completion date
2028-01-31
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Knee, Replacement

Brief summary

This study compares the analgesic efficacy of single-dose adductor canal block (sACB) versus continuous-dose adductor canal block (cACB) for postoperative pain management in total knee replacement patients. To ensure a high level of clinical accuracy, the investigation specifically focuses on a cACB cohort where ultrasound confirmation ensures the catheter remains correctly positioned for a full 48 hours. Participants are assigned to groups using a 1:1 randomization protocol via computer-generated tables to eliminate selection bias. Clinical consistency is maintained by using identical pharmacological agents across both groups: 0.5% Heavy Bupivacaine for spinal anesthesia and 0.5% ropivacaine with 1:200,000 epinephrine for the nerve block itself. Furthermore, both groups adhere to a standardized multimodal analgesic schedule to control for external variables. In the cACB group, intravenous patient-controlled analgesia (IV PCA) serves as a designated rescue therapy should the catheter fail. The primary technical evaluation occurs 48 hours post-surgery, utilizing ultrasound to verify catheter placement and quantify pain levels. Beyond immediate recovery, the study evaluates long-term success through Patient-Reported Outcome Measures (PROMs) at a 12-week follow-up, focusing on functional restoration and the patient's overall quality of life. By isolating the variable of catheter stability, the research aims to provide a definitive comparison of whether the continuous delivery of local anesthetic offers a statistically significant clinical advantage over a single-dose administration in the context of modern orthopedic recovery protocols.

Interventions

PROCEDUREContinuous ACB

Adductor canal block, a lower extremity nerve block technique for postoperative pain control, is performed under ultrasound guidance for patients undergoing total knee arthroplasty, and is carried out by inserting a catheter. The catheter is connected to a PCA pump following insertion, with a continuous infusion rate for two days post-surgery.

PROCEDURESingle-shot ACB

Adductor canal block, a lower extremity nerve block technique for postoperative pain control, is performed under ultrasound guidance for patients undergoing total knee arthroplasty, and is carried out by a single-shot local anesthetic administration.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 40-80 yrs * Scheduled for unilateral total knee arthroplatsy * ASA I-III * BMI 18-35 kg/㎡ * Able to read and understand consent form

Exclusion criteria

* Allergy to local anesthetics * Infection at the block site * History of neuropathy or peripheral nerve disease * Coagulation disorders or use of anticoagulants (if discontinuation is not possible) * Communication disorders or cognitive impairment * Chronic opioid use (≥30 MME/day, 3 months or more) * Severe chronic pain (NRS ≥7/10, 3 months or more) * Renal impairment (eGFR \<30 mL/min/1.73m²) * Hepatic impairment (Child-Pugh C) * Blood coagulation disorders * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain score at rest (Area Under Curve, AUC)postoperative 48 hours48-hour postoperative pain score at rest (Area Under Curve, AUC) using NRS.

Contacts

CONTACTeunjung Kim
natlis@yuhs.ac

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026